The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Britain's Got Talent star Ryan Howell has died of bone cancer, aged just 18.
Community Furniture Aid in Bridgend says families have been left sleeping on hostel floors due to a lack of donations.
A 'bizarre' combination of poisonous metals was found in the body of a Cardiff woman allegedly murdered by her lover, a court has heard.